Günter Blobel, a Nobel Prize-winning Rockefeller biologist who discovered the mechanisms by which proteins are targeted for delivery to specific locations within cells, died February 18 at 81.
As inaugural Sanders Director Dr. Michael Foley is set to depart the Tri-Institutional Therapeutics Discovery Institute later this year, two projects from a portfolio of 57 that the Tri-I TDI has supported are now ready for the next phase of therapeutic development—a phase intended to lead to investigational new drugs.
Ruta, who explores how brains produce such flexible responses to fixed stimuli, has been promoted to Gabrielle H. Reem and Herbert J. Kayden associate professor.
Kronauer has been promoted to associate professor. He has dedicated his laboratory to investigating the molecular basis underlying complex social behavior among insects.
Cohen was an emeritus faculty member at The Rockefeller University and leader in statistical physics and nonequilibrium statistical mechanics. He died September 24 at the age of 94.
Stubbe is being recognized for illuminating the processes that drive DNA replication and repair. Her research has led to the development of several cancer therapies.
The ranking evaluates how research articles are cited in patents, showing the influence of research on the development of products and services.
The fourth annual science festival drew more than 1,000 school-age children and their families to campus. The young explorers participated in hands-on experiments and interactive demonstrations led by scientists.
The Rockefeller University today awards doctoral degrees to 23 students who have completed their studies in bioscience. In addition, four distinguished scientists—Anthony B. Evnin, Mary-Claire King, Matthew Meselson, and Steven Weinberg—will receive honorary doctor of science degrees.
Reem–Kayden Early-Career Innovation Award is established to support newly promoted associate professors at Rockefeller
The unique award, funded by a $7 million gift, is designed to encourage Rockefeller’s early-career faculty members to pursue the most imaginative science in the years leading to a tenure decision. All heads of laboratories are eligible upon their promotion to associate professor.
Rockefeller’s Board of Trustees elected new member Pablo G. Legorreta, the founder and CEO of Royalty Pharma, at their February 15 meeting. With his election, the university has 49 voting members.